Ferdinand Kappes

1.9k total citations
38 papers, 1.4k citations indexed

About

Ferdinand Kappes is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Ferdinand Kappes has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Cell Biology. Recurrent topics in Ferdinand Kappes's work include Nuclear Structure and Function (26 papers), Genomics and Chromatin Dynamics (15 papers) and RNA Research and Splicing (14 papers). Ferdinand Kappes is often cited by papers focused on Nuclear Structure and Function (26 papers), Genomics and Chromatin Dynamics (15 papers) and RNA Research and Splicing (14 papers). Ferdinand Kappes collaborates with scholars based in Germany, United States and China. Ferdinand Kappes's co-authors include David M. Markovitz, Claudia Gruss, Rolf Knippers, Tanja Waldmann, Michael S. Khodadoust, Elisa Ferrando‐May, Nirit Mor‐Vaknin, Maureen Legendre, Susanne I. Wells and Honggang Hu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Ferdinand Kappes

36 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ferdinand Kappes Germany 23 1.2k 411 158 140 138 38 1.4k
Willem den Besten United States 16 938 0.8× 418 1.0× 159 1.0× 206 1.5× 93 0.7× 20 1.2k
Alexander L. Kovalchuk United States 21 616 0.5× 291 0.7× 174 1.1× 51 0.4× 398 2.9× 53 1.2k
Nabeel R. Yaseen United States 18 879 0.7× 158 0.4× 181 1.1× 80 0.6× 165 1.2× 34 1.1k
Winifred Keeble United States 19 909 0.8× 207 0.5× 136 0.9× 235 1.7× 195 1.4× 28 1.2k
Taiju Utsugisawa Japan 15 772 0.7× 285 0.7× 188 1.2× 64 0.5× 84 0.6× 39 1.0k
Seetha Srinivasan United States 13 695 0.6× 312 0.8× 34 0.2× 117 0.8× 100 0.7× 14 977
Alwin Kraemer Germany 12 485 0.4× 290 0.7× 241 1.5× 174 1.2× 49 0.4× 22 899
Michael H. Neale United Kingdom 15 514 0.4× 371 0.9× 34 0.2× 76 0.5× 98 0.7× 26 820
Lucy T.C. Peltenburg Netherlands 19 755 0.6× 484 1.2× 42 0.3× 67 0.5× 435 3.2× 25 1.3k
Konstantin S. Spirin United States 12 651 0.6× 449 1.1× 39 0.2× 102 0.7× 56 0.4× 15 1.1k

Countries citing papers authored by Ferdinand Kappes

Since Specialization
Citations

This map shows the geographic impact of Ferdinand Kappes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferdinand Kappes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferdinand Kappes more than expected).

Fields of papers citing papers by Ferdinand Kappes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferdinand Kappes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferdinand Kappes. The network helps show where Ferdinand Kappes may publish in the future.

Co-authorship network of co-authors of Ferdinand Kappes

This figure shows the co-authorship network connecting the top 25 collaborators of Ferdinand Kappes. A scholar is included among the top collaborators of Ferdinand Kappes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferdinand Kappes. Ferdinand Kappes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Zhenyu, et al.. (2025). Detection of nontoxic BoNT/A levels in post-facial Botox injection breastmilk. PubMed. 4. 1480515–1480515. 1 indexed citations
2.
Johnstone, Megan, et al.. (2025). DEK promotes mammary hyperplasia and is associated with H3K27me3 epigenetic modifications. Life Science Alliance. 8(9). e202503230–e202503230.
3.
Diaspro, Alberto, et al.. (2023). DEK oncoprotein participates in heterochromatin replication via SUMO-dependent nuclear bodies. Journal of Cell Science. 136(23). 2 indexed citations
4.
Capitano, Maegan L., Nirit Mor‐Vaknin, Anjan K. Saha, et al.. (2019). Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling. PMC. 2 indexed citations
5.
Zanacchi, Francesca Cella, et al.. (2019). The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress. PLoS ONE. 14(8). e0213130–e0213130. 5 indexed citations
6.
Bütepage, Mareike, Christian Preisinger, Alex von Kriegsheim, et al.. (2018). Nucleolar-nucleoplasmic shuttling of TARG1 and its control by DNA damage-induced poly-ADP-ribosylation and by nucleolar transcription. Scientific Reports. 8(1). 6748–6748. 37 indexed citations
7.
Smith, Eric A., Anil G. Jegga, Ferdinand Kappes, et al.. (2017). The nuclear DEK interactome supports multi‐functionality. Proteins Structure Function and Bioinformatics. 86(1). 88–97. 17 indexed citations
8.
Smith, Eric A., Boris Gole, Nicholas A. Willis, et al.. (2017). DEK is required for homologous recombination repair of DNA breaks. Scientific Reports. 7(1). 44662–44662. 26 indexed citations
9.
Deutzmann, Anja, et al.. (2014). The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress. Oncogene. 34(32). 4270–4277. 31 indexed citations
10.
Contreras-Galindo, Rafael, Mark H. Kaplan, Shirley He, et al.. (2013). HIV infection reveals widespread expansion of novel centromeric human endogenous retroviruses. Genome Research. 23(9). 1505–1513. 65 indexed citations
11.
Broxmeyer, Hal E., Ferdinand Kappes, Nirit Mor‐Vaknin, et al.. (2011). DEK Regulates Hematopoietic Stem Engraftment and Progenitor Cell Proliferation. Stem Cells and Development. 21(9). 1449–1454. 34 indexed citations
12.
Kappes, Ferdinand, Michael S. Khodadoust, Limin Yu, et al.. (2011). DEK expression in melanocytic lesions. Human Pathology. 42(7). 932–938. 25 indexed citations
13.
Mor‐Vaknin, Nirit, Ferdinand Kappes, Maureen Legendre, et al.. (2010). DEK in the synovium of patients with juvenile idiopathic arthritis: Characterization of DEK antibodies and posttranslational modification of the DEK autoantigen. Arthritis & Rheumatism. 63(2). 556–567. 58 indexed citations
14.
Kappes, Ferdinand, Jörg Fahrer, Michael S. Khodadoust, et al.. (2008). DEK Is a Poly(ADP-Ribose) Acceptor in Apoptosis and Mediates Resistance to Genotoxic Stress. Molecular and Cellular Biology. 28(10). 3245–3257. 82 indexed citations
15.
Devany, Matthew, Ferdinand Kappes, Kuan‐Ming Chen, David M. Markovitz, & Hiroshi Matsuo. (2008). Solution NMR structure of the N‐terminal domain of the human DEK protein. Protein Science. 17(2). 205–215. 21 indexed citations
17.
Grasemann, Corinna, Harald Stephan, Andreas Schüler, et al.. (2005). Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma. Oncogene. 24(42). 6441–6449. 89 indexed citations
18.
Hiller, Ekkehard, et al.. (2004). Protein kinase CK2 phosphorylates the cell cycle regulatory protein Geminin. Biochemical and Biophysical Research Communications. 315(4). 1011–1017. 22 indexed citations
19.
Waldmann, Tanja, et al.. (2004). The DEK protein—an abundant and ubiquitous constituent of mammalian chromatin. Gene. 343(1). 1–9. 98 indexed citations
20.
Kappes, Ferdinand, et al.. (2001). Subcellular Localization of the Human Proto-oncogene Protein DEK. Journal of Biological Chemistry. 276(28). 26317–26323. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026